Ausgabe 1/1998
Inhalt (7 Artikel)
Induction of anti-idiotypic humoral and cellular immune responses by a murine monoclonal antibody recognizing the ovarian carcinoma antigen CA125 encapsulated in biodegradable microspheres
Jie Ma, John Samuel, Glen S. Kwon, Antoine A. Noujaim, Ragupathy Madiyalakan
Immunopotentiation with low-dose cyclophosphamide in the active specific immunotherapy of cancer
Katherine K. Bass, Michael J. Mastrangelo
Tumour-specific MHC-class-II-restricted responses after in vitro sensitization to synthetic peptides corresponding to gp100 and Annexin II eluted from melanoma cells
Kun Li, Medi Adibzadeh, Thomas Halder, Hubert Kalbacher, Susanne Heinzel, Claudia Müller, Jesper Zeuthen, Graham Pawelec
Induction of HLA-unrestricted and HLA-class-II-restricted cytotoxic T lymphocytes against MUC-1 from patients with colorectal carcinomas using recombinant MUC-1 vaccinia virus
Junji Akagi, Kazuhiro Nakagawa, Hiroshi Egami, Michio Ogawa
Biodistribution of 111In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01
Helma M. Prinssen, Carla F. M. Molthoff, René H. M. Verheijen, Tim J. Broadhead, Peter Kenemans, Jan C. Roos, Quentin Davies, Arjan C. van Hof, Malcolm Frier, Wim den Hollander, Abraham J. Wilhelm, Terry S. Baker, Mark Sopwith, E. Malcolm Symonds, Alan C. Perkins
Immunization with a tumor-cell-lysate-loaded autologous-antigen-presenting-cell-based vaccine in melanoma
Nitya G. Chakraborty, Jonathan R. Sporn, Anne F. Tortora, Scott H. Kurtzman, Harold Yamase, M. T. Ergin, Bijay Mukherji
Effect of interleukin-8 on production of tumor-associated substances and autocrine growth of human liver and pancreatic cancer cells
Megumi Miyamoto, Yukihiro Shimizu, Kazuhiko Okada, Yoshiro Kashii, Kiyohiro Higuchi, Akiharu Watanabe